Evaluation and Optimization of Ultrasound and/or MRI Hardware and Software

NCT ID: NCT00640107

Last Updated: 2024-06-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

30 participants

Study Classification

OBSERVATIONAL

Study Start Date

2007-10-31

Study Completion Date

2030-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to evaluate and optimize ultrasound and/or MRI hardware and software in both existing ultrasound/MRI units as well as in newly installed commercially available ultrasound/MRI units. The study also serves to familiarize the ultrasound/MRI technician staff with how to operate newly installed software sequences or hardware. The information obtained from this study will be utilized to optimize new software sequences and hardware that have been installed on the UMU ultrasound/MRI scanners. This will offer ultrasound/MRI technologists ample time to become familiar with the operation of new equipment. More specifically, the objectives of this study are to maximize contrast to noise (CNR) and signal to noise (SNR) ratios for new imaging sequences and hardware to obtain high quality images, maximize the potential of new machines and associated software/hardware to obtain the highest quality of images, and obtain the highest quality images in reasonable scan time to minimize patient motion.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Magnetic Resonance Imaging (MRI) has been utilized for 20 years as a clinical and research tool at SUNY Upstate Medical University. Currently, there are five (5) MR (1 low-field 0.2 Tesla, 3 high-field 1.5 Tesla and 1 3.0 Tesla) units in use on the university campus. During this time, new imaging sequences and hardware including smaller more powerful magnets and faster computers have been developed that assist in the diagnosis of many disease processes. MR Angiography, MR Spectroscopy, diffusion weighted imaging and a dedicated combination Neurovascular head and neck coil are just several of the many imaging sequences and specialized coils that have been developed over the last several years.

New imaging sequences and hardware including 4.0 and 7.0 Tesla magnets are currently undergoing development and testing at several universities in the United States and worldwide. As a consequence of the many new innovations in MR imaging we must periodically upgrade our existing MR units and on occasion replace one of our existing MR units or purchase a new MR unit. This will ensure that we have the most up to date MR equipment to provide state of the art diagnostic imaging capabilities at University Hospital. The new imaging sequences and/or hardware must be optimized for each MR unit to achieve the highest signal to noise (SNR) and contrast to noise (CNR) ratios in a reasonable scan time. This practice is routinely performed at every university and private hospital as well as outpatient imaging center when a new MR unit is installed and when an existing unit is upgraded.

Ultrasound imaging has been a component of the Radiology Department since 1975 and used as a clinical and research tool. Presently our machines include the GE's models: Logic E9, S8, Logic (, P5, P6, Logic Book, Phillips IU22, SonoSite Turbo (multiple units), Siemens Acuson (x3 units) and a Siemens X300. There are updated ultrasound machines that allow color Doppler images and elastography acquisition ability. Upgrades for software and hardware are on an ongoing basis along with new applications and imaging protocols.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Able to Understand and Sign Informed Consent Disclosure (ICD)
* Healthy Volunteers Aged 18-70
* Healthy Volunteers with No History of Aneurysm Clips, Cardiac Pacemakers, Claustrophobia, Neurostimulators, and Pregnancy.

Exclusion Criteria

* Subjects \> 300 Pounds
* Subjects \< 18 Years Old
* Subjects \> 70 Years Old
* Subjects w/ Aneurysm Clips
* Subjects w/ Cardiac Pacemakers
* Subjects w/ Claustrophobia
* Subjects w/ Neurostimulators
* Subjects w/ Pregnancy
Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

State University of New York - Upstate Medical University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Marzieh Nezamzadeh

Diagnostic Radiology Physicist

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Marzieh Nezamzadeh, PhD

Role: PRINCIPAL_INVESTIGATOR

State University of New York - Upstate Medical University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

SUNY Upstate Medical University

Syracuse, New York, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Donna Bolourchi, BSc

Role: CONTACT

(315) 464-7424

Kyra Crossett, BSc

Role: CONTACT

(315) 464-5098

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Donna Bolourchi, BS

Role: primary

315-464-7424

Kyra Crossett, BS

Role: backup

315-464-5098

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SUNYUMU 247517

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Phrenic Identification in the ICU
NCT05875883 ACTIVE_NOT_RECRUITING